Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:21 PM
Ignite Modification Date:
2025-12-24 @ 12:21 PM
NCT ID:
NCT00126061
Eligibility Criteria:
Inclusion Criteria:
* Willing to sign informed consent before screening examinations are performed and before the study drug is administered
* Males \> 18 years of age
* Subjects with documented (60 second rhythm strip) symptomatic atrial fibrillation or flutter (duration \> 3 hours and \< 45 days) at the time of randomization
* Subjects who are in no distress and hemodynamically stable (supine systolic blood pressure \> 90 mmHg and diastolic blood pressure \< 105 mmHg)
Exclusion Criteria:
* Acute myocardial infarction and cerebrovascular accidents
* Coronary and heart failure symptoms
* Life-threatening ventricular arrhythmias and electrocardiogram (ECG) abnormalities
* Electrolyte abnormalities
* Concurrent antiarrhythmic treatments
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT00126061
Study Brief:
Protocol Section:
NCT00126061